• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫介导性小脑共济失调的罕见病因:诊断挑战

Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges.

作者信息

Hadjivassiliou Marios, Manto Mario, Mitoma Hiroshi

机构信息

Academic Department of Neurosciences, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK.

Service de Neurologie, Médiathèque Jean Jacquy, CHU-Charleroi, 6000 Charleroi, Belgium.

出版信息

Brain Sci. 2022 Aug 30;12(9):1165. doi: 10.3390/brainsci12091165.

DOI:10.3390/brainsci12091165
PMID:36138901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9496914/
Abstract

The cerebellum is particularly enriched in antigens and represents a vulnerable target to immune attacks. Immune-mediated cerebellar ataxias (IMCAs) have diverse etiologies, such as gluten ataxia (GA), post-infectious cerebellitis (PIC), Miller Fisher syndrome (MFS), paraneoplastic cerebellar degeneration (PCD), opsoclonus myoclonus syndrome (OMS), and anti-GAD ataxia. Apart from these well-established entities, cerebellar ataxia (CA) occurs also in association with autoimmunity against ion channels and related proteins, synaptic adhesion/organizing proteins, transmitter receptors, glial cells, as well as the brainstem antigens. Most of these conditions manifest diverse neurological clinical features, with CAs being one of the main clinical phenotypes. The term primary autoimmune cerebellar ataxia (PACA) refers to ataxic conditions suspected to be autoimmune even in the absence of specific well-characterized pathogenic antibody markers. We review advances in the field of IMCAs and propose a clinical approach for the understanding and diagnosis of IMCAs, focusing on rare etiologies which are likely underdiagnosed. The frontiers of PACA are discussed. The identification of rare immune ataxias is of importance since they are potentially treatable and may lead to a severe clinical syndrome in absence of early therapy.

摘要

小脑富含抗原,是免疫攻击的易损靶点。免疫介导的小脑性共济失调(IMCA)病因多样,如麸质共济失调(GA)、感染后小脑炎(PIC)、米勒-费希尔综合征(MFS)、副肿瘤性小脑变性(PCD)、眼阵挛-肌阵挛综合征(OMS)和抗谷氨酸脱羧酶共济失调。除了这些已明确的疾病,小脑性共济失调(CA)也与针对离子通道及相关蛋白、突触黏附/组织蛋白、神经递质受体、神经胶质细胞以及脑干抗原的自身免疫有关。这些疾病大多表现出多样的神经临床特征,CA是主要临床表型之一。原发性自身免疫性小脑性共济失调(PACA)一词指即使在缺乏特定特征明确的致病性抗体标志物的情况下,也怀疑为自身免疫性的共济失调疾病。我们综述了IMCA领域的进展,并提出了一种理解和诊断IMCA的临床方法,重点关注可能诊断不足的罕见病因。讨论了PACA的前沿问题。识别罕见的免疫性共济失调很重要,因为它们有可能得到治疗,且在缺乏早期治疗的情况下可能导致严重的临床综合征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7007/9496914/8e7203395270/brainsci-12-01165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7007/9496914/8e7203395270/brainsci-12-01165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7007/9496914/8e7203395270/brainsci-12-01165-g001.jpg

相似文献

1
Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges.免疫介导性小脑共济失调的罕见病因:诊断挑战
Brain Sci. 2022 Aug 30;12(9):1165. doi: 10.3390/brainsci12091165.
2
[Immune-Mediated Cerebellar Ataxias].[免疫介导的小脑性共济失调]
Brain Nerve. 2023 Jun;75(6):737-747. doi: 10.11477/mf.1416202409.
3
Recent Advances in Immune-Mediated Cerebellar Ataxias: Pathogenesis, Diagnostic Approaches, Therapies, and Future Challenges-Editorial.免疫介导性小脑共济失调的最新进展:发病机制、诊断方法、治疗及未来挑战——述评
Brain Sci. 2023 Nov 24;13(12):1626. doi: 10.3390/brainsci13121626.
4
Immune Ataxias: The Continuum of Latent Ataxia, Primary Ataxia and Clinical Ataxia.免疫性共济失调:潜伏性共济失调、原发性共济失调和临床性共济失调的连续谱。
J Integr Neurosci. 2024 Apr 12;23(4):79. doi: 10.31083/j.jin2304079.
5
Recent advances in diagnosis of immune-mediated cerebellar ataxias: novel concepts and fundamental questions on autoimmune mechanisms.免疫介导小脑共济失调的诊断新进展:自身免疫机制的新概念和基本问题。
J Neurol. 2024 Oct;271(10):7046-7053. doi: 10.1007/s00415-024-12596-7. Epub 2024 Jul 25.
6
Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms.免疫介导的小脑性共济失调:基于免疫和生理机制的临床诊断与治疗
J Mov Disord. 2021 Jan;14(1):10-28. doi: 10.14802/jmd.20040. Epub 2021 Jan 12.
7
Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.免疫介导的小脑共济失调:实用指南与治疗挑战。
Curr Neuropharmacol. 2019;17(1):33-58. doi: 10.2174/1570159X16666180917105033.
8
[Immune-Mediated Cerebellar Ataxias].[免疫介导的小脑性共济失调]
Brain Nerve. 2021 May;73(5):611-619. doi: 10.11477/mf.1416201805.
9
Immune-mediated ataxias: Guide to clinicians.免疫介导性共济失调:临床医生指南
Parkinsonism Relat Disord. 2023 Dec;117:105861. doi: 10.1016/j.parkreldis.2023.105861. Epub 2023 Sep 20.
10
Treatable Ataxias: How to Find the Needle in the Haystack?可治疗的共济失调:如何在大海捞针?
J Mov Disord. 2022 Sep;15(3):206-226. doi: 10.14802/jmd.22069. Epub 2022 Sep 7.

引用本文的文献

1
Blood-Brain Barrier Disruption in Neuroimmunological Disease.神经免疫性疾病中的血脑屏障破坏。
Int J Mol Sci. 2024 Oct 2;25(19):10625. doi: 10.3390/ijms251910625.
2
Recent advances in diagnosis of immune-mediated cerebellar ataxias: novel concepts and fundamental questions on autoimmune mechanisms.免疫介导小脑共济失调的诊断新进展:自身免疫机制的新概念和基本问题。
J Neurol. 2024 Oct;271(10):7046-7053. doi: 10.1007/s00415-024-12596-7. Epub 2024 Jul 25.
3
Neurological Conundrum: A Case of Cerebellar Hemispheric Enlargement and Atypical Symptoms.

本文引用的文献

1
Autoimmune glial fibrillary acidic protein astrocytopathy presented as ataxia, myoclonus and bulbar syndrome: a case report and review of the literature.自身免疫性胶质纤维酸性蛋白星形细胞病表现为共济失调、肌阵挛和延髓综合征:一例报告并文献复习
BMJ Neurol Open. 2021 Oct 27;3(2):e000142. doi: 10.1136/bmjno-2021-000142. eCollection 2021.
2
Mild Cognitive Impairment in Chronic Brain Injury Associated with Serum Anti-AP3B2 Autoantibodies: Report and Literature Review.慢性脑损伤中与血清抗AP3B2自身抗体相关的轻度认知障碍:病例报告及文献综述
Brain Sci. 2021 Sep 14;11(9):1208. doi: 10.3390/brainsci11091208.
3
Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease.
神经学难题:一例小脑半球增大及非典型症状病例
Cureus. 2024 Apr 12;16(4):e58096. doi: 10.7759/cureus.58096. eCollection 2024 Apr.
4
Recent Advances in Immune-Mediated Cerebellar Ataxias: Pathogenesis, Diagnostic Approaches, Therapies, and Future Challenges-Editorial.免疫介导性小脑共济失调的最新进展:发病机制、诊断方法、治疗及未来挑战——述评
Brain Sci. 2023 Nov 24;13(12):1626. doi: 10.3390/brainsci13121626.
5
Neurological update: neuro-otology 2023.神经科最新动态:神经耳科学 2023 年版。
J Neurol. 2023 Dec;270(12):6170-6192. doi: 10.1007/s00415-023-11922-9. Epub 2023 Aug 17.
6
Effects of non-invasive brain stimulation for degenerative cerebellar ataxia: a protocol for a systematic review and meta-analysis.非侵入性脑刺激治疗退行性小脑共济失调的效果:系统评价和荟萃分析方案。
BMJ Open. 2023 Jun 29;13(6):e073526. doi: 10.1136/bmjopen-2023-073526.
在病情反复的抗IgLON5病中积极免疫治疗的延迟获益
Neurol Neuroimmunol Neuroinflamm. 2021 May 13;8(4). doi: 10.1212/NXI.0000000000001009. Print 2021 Jul.
4
Recurrent Ataxia and Dystonia with Anti-Neurochondrin Autoantibodies.伴有抗神经软骨素自身抗体的复发性共济失调和肌张力障碍
Neuropediatrics. 2021 Jun;52(3):228-229. doi: 10.1055/s-0040-1722675. Epub 2021 Jan 14.
5
Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms.免疫介导的小脑性共济失调:基于免疫和生理机制的临床诊断与治疗
J Mov Disord. 2021 Jan;14(1):10-28. doi: 10.14802/jmd.20040. Epub 2021 Jan 12.
6
Clinical Characteristics and Management of 50 Patients with Anti-GAD Ataxia: Gluten-Free Diet Has a Major Impact.50 例抗 GAD 抗体阳性共济失调患者的临床特点和处理:无麸质饮食有重要影响。
Cerebellum. 2021 Apr;20(2):179-185. doi: 10.1007/s12311-020-01203-w. Epub 2020 Oct 21.
7
Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis.抗 mGluR1 脑炎的临床特征、预后因素和抗体效应。
Neurology. 2020 Dec 1;95(22):e3012-e3025. doi: 10.1212/WNL.0000000000010854. Epub 2020 Sep 14.
8
Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features.抗接触蛋白相关蛋白2(CASPR2)临床表型与人类白细胞抗原(HLA)及免疫学特征相关。
J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1076-1084. doi: 10.1136/jnnp-2020-323226. Epub 2020 Jul 10.
9
Treatment of Primary Autoimmune Cerebellar Ataxia with Mycophenolate.麦考酚酯治疗原发性自身免疫性小脑性共济失调
Cerebellum. 2020 Oct;19(5):680-684. doi: 10.1007/s12311-020-01152-4.
10
GAD antibodies in neurological disorders - insights and challenges.神经疾病中的 GAD 抗体:研究进展与挑战。
Nat Rev Neurol. 2020 Jul;16(7):353-365. doi: 10.1038/s41582-020-0359-x. Epub 2020 May 26.